Mirae Asset Global Investments Co., Ltd. Zentalis Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 31,587 shares of ZNTL stock, worth $116,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,587
Previous 40,574
22.15%
Holding current value
$116,871
Previous $614,000
19.06%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ZNTL
# of Institutions
142Shares Held
76.3MCall Options Held
68.2KPut Options Held
2.3K-
Matrix Capital Management Company, LP Waltham, MA14MShares$51.7 Million2.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA11.6MShares$42.8 Million2.94% of portfolio
-
Black Rock Inc. New York, NY4.65MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$16.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.85MShares$14.3 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $211M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...